A case-control follow-up study for disease-specific mortality

Biometrics
Marshall M Joffe

Abstract

Case-control studies often rely on subjects to report their own screening or exposure information: this information is often obtained from cases after the event of interest has occurred. This is problematic for mortality outcomes, because dead subjects cannot report the desired information. To avoid this problem, Weiss and Lazovich (1996, American Journal of Epidemiology 143, 319-322) proposed obtaining exposure or screening information from potential cases, i.e., subjects diagnosed with disease, at the time of disease diagnosis, and also from a referent series. The design is best viewed as a new scheme for sampling from a cohort. I review estimation of the effects of time-varying screening or exposure in cohort studies, using a new factorization. I then show how this factorization, together with ignorability assumptions, allows valid estimation from these new designs. Even when the sampling fraction of nondiseased subjects is unknown, causal risk ratios are estimable if diagnosis is rare in the cohort. I illustrate and compare conventional and new methods with data from the Health Insurance Plan study.

References

Sep 1, 1978·American Journal of Epidemiology·R R Neutra, M E Drolette
Dec 1, 1991·International Journal of Epidemiology·A J Sasco
Jan 1, 1991·Journal of Clinical Epidemiology·R J ConnorD L Weed
May 15, 1991·American Journal of Epidemiology·D R Friedman, N Dubin
Mar 1, 1991·International Journal of Epidemiology·S M Moss
Aug 1, 1990·Statistics in Medicine·W D Flanders, I M Longini
Jun 1, 1989·Statistics in Medicine·J Robins
Sep 1, 1986·International Journal of Epidemiology·S Greenland, J M Robins
Feb 1, 1986·American Journal of Epidemiology·C Poole
Sep 1, 1982·American Journal of Epidemiology·S Greenland, D C Thomas
Nov 15, 1994·Statistics in Medicine·S G Baker, K S Lindeman
Jan 15, 1996·American Journal of Epidemiology·R S HosekA J Sasco
Dec 1, 1996·International Journal of Epidemiology·S Greenland
Apr 3, 1998·American Journal of Epidemiology·D L Weed, S D Hursting
Oct 21, 1999·Journal of Clinical Epidemiology·T R Church

❮ Previous
Next ❯

Citations

Apr 1, 1986·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·W de KievietN G Abeling
Dec 17, 2009·Biometrics·Wenguang SunSteven M Brunelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K WelchT Ogbuokiri
Journal of the American Society of Nephrology : JASN
Steven M BrunelliHarold I Feldman
© 2022 Meta ULC. All rights reserved